19.75
Precedente Chiudi:
$19.34
Aprire:
$19.34
Volume 24 ore:
57,973
Relative Volume:
0.70
Capitalizzazione di mercato:
$411.17M
Reddito:
$-609.47M
Utile/perdita netta:
$-937.91M
Rapporto P/E:
-0.6592
EPS:
-29.96
Flusso di cassa netto:
$96.09M
1 W Prestazione:
+7.51%
1M Prestazione:
+12.15%
6M Prestazione:
+44.27%
1 anno Prestazione:
+53.82%
Shoulder Innovations Inc Stock (SI) Company Profile
Nome
Shoulder Innovations Inc
Settore
Industria
Telefono
616-566-0286
Indirizzo
1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS
Compare SI vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
SI
Shoulder Innovations Inc
|
19.75 | 411.17M | -609.47M | -937.91M | 96.09M | -29.96 |
|
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-07-28 | Iniziato | UBS | Buy |
| 2025-08-25 | Iniziato | BTIG Research | Buy |
| 2025-08-25 | Iniziato | Goldman | Buy |
| 2025-08-25 | Iniziato | Jefferies | Buy |
| 2025-08-25 | Iniziato | Piper Sandler | Overweight |
| 2023-03-06 | Downgrade | Compass Point | Neutral → Sell |
| 2023-03-06 | Downgrade | Wedbush | Neutral → Underperform |
| 2023-03-02 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-03-02 | Downgrade | Compass Point | Buy → Neutral |
| 2023-03-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-03-01 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| 2023-01-09 | Downgrade | Wedbush | Outperform → Neutral |
| 2023-01-06 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Downgrade | Craig Hallum | Buy → Hold |
| 2023-01-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-12 | Reiterato | Wedbush | Outperform |
| 2022-12-05 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-11-10 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-10-26 | Downgrade | Goldman | Buy → Neutral |
| 2022-10-06 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2022-08-04 | Iniziato | BTIG Research | Buy |
| 2022-06-13 | Iniziato | Wells Fargo | Overweight |
| 2022-06-09 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-03-21 | Iniziato | BofA Securities | Buy |
| 2022-01-20 | Aggiornamento | Goldman | Neutral → Buy |
| 2021-12-16 | Iniziato | B. Riley Securities | Buy |
| 2021-11-11 | Iniziato | JP Morgan | Overweight |
| 2021-11-08 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-09-27 | Iniziato | Morgan Stanley | Overweight |
| 2021-06-14 | Iniziato | Goldman | Neutral |
| 2021-01-14 | Downgrade | Barclays | Overweight → Equal Weight |
| 2020-12-22 | Iniziato | Wedbush | Outperform |
| 2020-12-17 | Aggiornamento | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-12-02 | Iniziato | Craig Hallum | Buy |
| 2020-10-16 | Iniziato | Compass Point | Buy |
| 2020-03-16 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-03 | Iniziato | Keefe Bruyette | Mkt Perform |
| 2019-12-02 | Iniziato | Barclays | Overweight |
| 2019-11-18 | Iniziato | Compass Point | Buy |
Mostra tutto
Shoulder Innovations Inc Borsa (SI) Ultime notizie
Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026 - AOL.com
Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026 - Yahoo Finance
Transcript: Shoulder Innovations Q2 2026 Earnings Conference Call - Benzinga
BTIG Maintains Shoulder Innovations(SI.US) With Buy Rating, Raises Target Price to $27 - Moomoo
Form 4 Shoulder Innovations Inc For: 11 October By Investing.com - Investing.com South Africa
Form 4 Shoulder Innovations Inc For: 11 October By Investing.com - Investing.com Nigeria
Shoulder Innovations launches limited release o... - Pluang
Shoulder Innovations begins limited release of InSet Go glenoid implant - StreetInsider
Shoulder Innovations Initiates Commercial Launch of the InSet® Go - PR Newswire
A new shoulder implant was used in its first operation. Its design cuts surgical steps. - Stock Titan
Shoulder Innovations Initiates Commercial Launch of the InSet® Go - TradingView
Form 4 Shoulder Innovations Inc For: 7 October By Investing.com - Investing.com Nigeria
Director fees become a 669-unit stock award at Shoulder Innovations (SI). - Stock Titan
Stock replaces cash fees as Shoulder Innovations (SI) awards Paul Buckman 1,275 stock units. - Stock Titan
Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook - Lelezard
Shoulder Innovations, Inc.(NYSE: SI) added to S&P Global BMI Index - marketscreener.com
Shoulder Innovations breaks ground on new headquarters as sales surge - Crain's Grand Rapids Business
Shoulder Innovations Partners with ALM Ortho on Bespoke Titanium Implants for Complex Shoulder Cases - 3D Printing Industry
Shareholder plans $187,706 stock sale in Shoulder Innovations (SI) - Stock Titan
Shoulder Innovations moving headquarters to Byron Township - Newsradio WOOD 1300 and 106.9 FM
Anticipating more growth, medical device company breaks ground on new HQ in Byron Township - WOODTV.com
Anticipating more growth, medical device company breaks ground on new HQ in Byron Township - WOODTV.com
Anticipating more growth, medical device company breaks ground on new HQ in Byron Township - Yahoo Finance
Kerry Olin Appointed Chief People Officer at Shoulder Innovations - hrtoday.in
Shoulder Innovations receives FDA clearance for titanium implant By Investing.com - Investing.com South Africa
Shoulder Innovations receives FDA clearance for titanium implant By Investing.com - Investing.com Nigeria
Shoulder Innovations receives FDA clearance for titanium implant By Investing.com - Investing.com Canada
Shoulder Innovations receives FDA clearance for titanium implant - investing.com
Shoulder Innovations Receives FDA 510(K) Clearance For N-22 Humeral Head And Initiates Full Commercial Launch - TradingView
Shoulder Innovations receives FDA clearance for titanium implant By Investing.com - Investing.com UK
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch - PR Newswire
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch - Yahoo Finance
About 10% to 15% of people test positive for metal sensitivity. Shoulder Innovations launches an implant. - Stock Titan
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - Ortho Spine News
Shoulder Innovations partners with ALM Ortho on implants - investing.com
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - STLtoday.com
Catalyst OrthoScience Announces Settlement of Patent Litigation with Shoulder Innovations - Business Wire
Silvergate ex-CEO blames Biden pressure for bank’s 2023 wind-down - Crypto Briefing
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - PR Newswire
Shoulder Innovations Collaborates With ALM Ortho to Introduce Implant for Shoulder Deformity - Yahoo Finance
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - Yahoo Finance
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - Morningstar
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience - Ortho Spine News
Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com India
Shoulder Innovations Settles Patent Dispute With Catalyst OrthoScience - marketscreener.com
Shoulder Innovations settles patent dispute with Catalyst - investing.com
Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com Canada
Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com UK
Shoulder Innovations Announces Settlement of - Moomoo
A patent fight over shoulder surgery ends in settlement. Terms remain confidential. - Stock Titan
Shoulder Innovations Inc Azioni (SI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Shoulder Innovations Inc Azioni (SI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ROBERT BALL | Officer |
Sep 14 '26 |
Proposed Sale |
18.45 |
10,175 |
187,706 |
0 |
| Ball Robert Joseph | CEO & Executive Chairman |
Sep 14 '26 |
Sale |
18.45 |
10,175 |
187,706 |
380,824 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 26 '26 |
Sale |
22.60 |
1,196 |
27,030 |
2,185,914 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 24 '26 |
Sale |
22.62 |
681 |
15,404 |
2,187,110 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 21 '26 |
Sale |
22.61 |
20,516 |
463,867 |
2,187,791 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 20 '26 |
Sale |
22.60 |
3,900 |
88,140 |
2,208,307 |
| Ahearn Matthew Fraser | Chief Operating Officer |
Aug 18 '26 |
Sale |
20.99 |
14,186 |
297,704 |
244,176 |
| Ahearn Matthew Fraser | Chief Operating Officer |
Aug 17 '26 |
Sale |
20.10 |
8,314 |
167,101 |
258,362 |
| MATTHEW AHEARN | Director |
Aug 17 '26 |
Proposed Sale |
20.73 |
22,500 |
466,425 |
0 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 06 '26 |
Sale |
22.60 |
2,095 |
47,347 |
2,212,207 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):